Singapore, July 14 -- Boehringer Ingelheim, one of the world's leading research-driven biopharmaceutical companies, has signed a Memorandum of Understanding (MoU) with Aster DM Healthcare, to collaborate on initiatives that strengthen medical education, patient engagement and disease awareness across Cardio-Renal-Metabolic (CRM) diseases in the UAE.

The signing ceremony was attended by representatives from both organisations, including Rahul Kadavakolu, Group Chief Marketing Officer, Aster DM Healthcare, and Ousama Alhaj, General Manager and Head of Human Pharma, Near East and UAE, and Ghaleb Al Ahdab, Head of Public and Government Affairs, Near East and UAE, representing Boehringer Ingelheim.

The strategic collaboration reflects a shar...